Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jun 20:2018:5931046.
doi: 10.1155/2018/5931046. eCollection 2018.

A Case of Atorvastatin-Associated Necrotizing Autoimmune Myopathy, Mimicking Idiopathic Polymyositis

Affiliations
Case Reports

A Case of Atorvastatin-Associated Necrotizing Autoimmune Myopathy, Mimicking Idiopathic Polymyositis

Ayushi Dixit et al. Case Rep Rheumatol. .

Abstract

Statin-induced necrotizing autoimmune myopathy (SINAM) is a rare side effect of statin use which manifests as progressive muscle weakness. Because statins are a widely prescribed medication for coronary artery disease, hyperlipidemia, and many other diseases, many patients are at risk of developing SINAM or one of the many other statin-induced myopathies. Due to identification of an antibody specific to this disease, we were able to diagnose SINAM in a patient whose symptoms had progressed to the extent that they were debilitating. Our case describes SINAM in a patient undergoing treatment with a statin for an extended period of time, diagnosis of the disease process, treatment, and resolution of symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Surgical pathology report.
Figure 2
Figure 2
Microscopic right quadriceps muscle biopsy showing necrotic muscle fibers and regenerating fibers. (a) Arrow pointing at necrotic muscle fiber (magnification 20x with alkaline phosphatase stain). (b) Arrow pointing at regenerating muscle fiber (magnification 20x with alkaline phosphatase stain).

References

    1. Young J. B., Ghobrial Autoimmune statin-induced myopathy: a case report. Journal of Community Hospital Internal Medicine Perspectives. 2015;5(4):p. 28374. doi: 10.3402/jchimp.v5.28374. - DOI - PMC - PubMed
    1. Joy T. R., Hegele R. A. Narrative review: statin-related myopathy. Annals of Internal Medicine. 2009;150(12):858–868. doi: 10.7326/0003-4819-150-12-200906160-00009. - DOI - PubMed
    1. Hansen K. E., Hildebrand J. P., Ferguson E. E., et al. Outcomes in 45 patients with statin-associated myopathy. Archives of Internal Medicine. 2005;165:2671–2676. doi: 10.1001/archinte.165.22.2671. - DOI - PubMed
    1. Christopher-Stine L., Casciola-Rosen L. A., Hong G., et al. A novel autoantibody recognizing 200 and 100 kDa proteins is associated with an immune-mediated necrotizing myopathy. Arthritis and Rheumatism. 2010;62(9):2757–2766. doi: 10.1002/art.27572. - DOI - PMC - PubMed
    1. Nichols L., Pfeifer K., Mammen A. L., et al. An unusual case of statin-induced myopathy: anti-HMGCoA necrotizing autoimmune myopathy. Journal of General Internal Medicine. 2015;30(12):1879–1883. doi: 10.1007/s11606-015-3303-9. - DOI - PMC - PubMed

Publication types

LinkOut - more resources